Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Dengue Vaccine in Healthy Children Aged 4 to 11 Years in Thailand
2014-001710-25Phase 2
- Sponsor
- Sanofi
- Start
- May 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of CYD-TDV in dengue fever, sponsored by Sanofi. Primary endpoint: Primary efficacy endpoint.
02
Drugs
CYD-TDV
03
Conditions
dengue fever
Beyond the preview
Go deeper on 2014-001710-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001710-25.